Invention Application
- Patent Title: TETRACYCLIC CDK9 KINASE INHIBITORS
- Patent Title (中): 四环素CDK9激酶抑制剂
-
Application No.: US14568153Application Date: 2014-12-12
-
Publication No.: US20150218165A1Publication Date: 2015-08-06
- Inventor: Robin Frey , Jianchun Gong , Zhiqin JI , Chunqiu Lai , Thomas Penning , Xiaohong Song , Andrew Souers , Yunsong Tong , Gui-Dong Zhu
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: ABBVIE INC.
- Current Assignee: ABBVIE INC.
- Current Assignee Address: US IL North Chicago
- Priority: CNPCT/CN2014/071865 20140206
- Main IPC: C07D471/16
- IPC: C07D471/16 ; A61K31/437 ; A61K31/55
Abstract:
Disclosed are compounds of Formula (Ia), and pharmaceutically acceptable salts thereof, wherein X, Y, R1, R2, R3A, R3B, and R4 are as described herein. The compounds may be used as agents in the treatment of diseases, including cancer. Also disclosed are pharmaceutical compositions comprising one or more compounds of Formula (Ia).
Public/Granted literature
- US09328112B2 Tetracyclic CDK9 kinase inhibitors Public/Granted day:2016-05-03
Information query
